Michael E. Rickey
31Patents
19h-index
17Co-inventors
74Inventor score
Filing activity: Mar 14, 1995 → Nov 22, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5792477A | Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent | Emerging Cross-Sectional Technologies | 145 | Expired |
| US5770231A | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles | Human Necessities | 126 | Expired |
| US5688801A | Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | Human Necessities | 111 | Expired |
| US5916598A | Preparation of biodegradable, biocompatible microparticles containing a biologically active agent | Emerging Cross-Sectional Technologies | 85 | Expired |
| US5965168A | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | Human Necessities | 80 | Expired |
| US6110503A | Preparation of biodegradable, biocompatible microparticles containing a biologically active agent | Emerging Cross-Sectional Technologies | 76 | Expired |
| US7456254B2 | Polymer-based sustained release device | Human Necessities | 69 | Expired |
| US7563871B2 | Polymer-based sustained release device | Human Necessities | 63 | Active |
| US7612176B2 | Polymer-based sustained release device | Human Necessities | 60 | Active |
| US6544559B2 | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | Human Necessities | 57 | Expired |
| US6803055B2 | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | Human Necessities | 36 | Expired |
| US6264987A | Method for preparing microparticles having a selected polymer molecular weight | Performing Operations; Transporting | 33 | Expired |
| US7118763B2 | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | Human Necessities | 31 | Expired |
| US6110921A | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | Human Necessities | 31 | Expired |
| US6824822B2 | Residual solvent extraction method and microparticles produced thereby | Performing Operations; Transporting | 28 | Expired |
| US6534092B2 | Method for preparing microparticles having a selected polymer molecular weight | Performing Operations; Transporting | 28 | Expired |
| US8431685B2 | Polymer-based sustained release device | Human Necessities | 24 | Active |
| US8461105B2 | Polymer-based sustained release device | Human Necessities | 23 | Active |
| US7223440B2 | Residual solvent extraction method and microparticles produced thereby | Performing Operations; Transporting | 20 | Expired |
| US6379704B2 | Method for preparing microparticles having a selected polymer molecular weight | Performing Operations; Transporting | 19 | Expired |
| US6368632B1 | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | Human Necessities | 19 | Expired |
| US8617613B2 | Polymer-based sustained release device | Human Necessities | 19 | Active |
| US8293871B2 | Poly(lactide-co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar | Human Necessities | 18 | Active |
| US6290983A | Preparation of biodegradable, biocompatible microparticles containing a biologically active agent | Emerging Cross-Sectional Technologies | 16 | Expired |
| US8877252B2 | Polymer-based sustained release device | Human Necessities | 15 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.